NPCE NeuroPace, Inc.
NeuroPace, Inc. (NPCE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: November 18, 2026 , by Huennekens R Scott .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Huennekens R Scott | Director | Buy | 12,500 | $8.29 | $103.7K | 12,500 | |
| Becker Joel | CHIEF EXECUTIVE OFFICER | Buy | 11,891 | $8.35 | $99.3K | 149,891 | |
| Williams Patrick F. | Chief Financial Officer | Buy | 11,891 | $8.34 | $99.1K | 79,399 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.